Sun Pharma Q4 Results: Profit jumps 34% YoY to Rs 2,654 crore, meets Street estimates

Revenue from operations increased 10% year-on-year to Rs 11,983 crore in the fourth quarter. The same stood at Rs 10,931 crore a year ago. The company's board has also approved a final dividend of Rs 5 per share and the same will be paid within the prescribed timeline.